Page 86 - 南京医科大学学报自然科学版
P. 86
第41卷第4期
·556 · 南 京 医 科 大 学 学 报 2021年4月
macroglobulinemia[J]. Leukemia,2019,33(11):2654- Assessment of red blood cell distribution width as a prog⁃
2661 nostic marker in chronic lymphocytic leukemia[J]. Onco⁃
[3] LIPPI G,PLEBANI M. Red blood cell distribution width target,2016,7(22):32846-32853
(RDW)and human pathology. One size fits all[J]. Clin [16] ZHOU S,FANG F,CHEN H,et al. Prognostic signifi⁃
Chem Lab Med,2014,52(9):1247-1249 cance of the red blood cell distribution width in diffuse
[4] KATSAROS M,PASCHOS P,GIOULEME O. Red cell large B⁃cell lymphoma patients[J]. Oncotarget,2017,8
distribution width as a marker of activity in inflammatory (25):40724-40731
bowel disease:a narrative review[J]. Ann Gastroenterol, [17] 王 鑫,吴重阳,曾鹏云,等. 红细胞分布宽度和纤维蛋
2020,33(4):348-354 白原水平对判断弥漫大B细胞淋巴瘤患者疗效及预后
[5] HU Z D,LIPPI G,MONTAGNANA M. Diagnostic and 的价值[J]. 中国实验血液学杂志,2020,28(1):153-159
prognostic value of red blood cell distribution width in [18] MIAO Y,ZHOU X H,GUO J J,et al. Association of red
sepsis:a narrative review[J]. Clin Biochem,2020,77:1-6 blood cell distribution width and outcomes in patients
[6] 王 箴,沈光贵,汪 彤,等. 红细胞分布宽度及其动态 with mantle cell lymphoma[J]. Cancer Med,2019,8(6):
变化在评估重症急性胰腺炎患者预后中的价值[J]. 南 2751-2758
[19] LUO H C,QUAN X Y,SONG X Y,et al. Red blood cell
京医科大学学报(自然科学版),2016,36(10):1218-
distribution width as a predictor of survival in nasal⁃type,
1221,1240
[7] PARIZADEH S M,JAFARZADEH ⁃ ESFEHANI R, extranodal natural killer/T ⁃ cell lymphoma[J]. Oncotar⁃
get,2017,8(54):92522-92535
BAHREYNI A,et al. The diagnostic and prognostic value
of red cell distribution width in cardiovascular disease; [20] WANG J,XIE X,CHENG F,et al. Evaluation of pretreat⁃
ment red cell distribution width in patients with multiple
current status and prospective[J]. Biofactors,2019,45
myeloma[J]. Cancer Biomark,2017,20(3):267-272
(4):507-516
[21] SWERDLOW S H,CAMPO E,PILERI S A,et al. The
[8] HAYBAR H,PEZESHKI S M,SAKI N. Evaluation of com⁃
plete blood count parameters in cardiovascular diseases: 2016 revision of the World Health Organization classifica⁃
tion of lymphoid neoplasms[J]. Blood,2016,127(20):
an early indicator of prognosis?[J]. Exp Mol Pathol,
2375-2390
2019,110:104267
[22] CAO X,KONG Y L,WANG L,et al. High plasma D⁃di⁃
[9] 杨滇宇,权文强,孙祖俊,等. RDW 在恶性肿瘤诊疗中
mer level is a poor prognostic factor for patients with
的最新应用[J]. 检验医学,2018,33(9):844-849
waldenström macroglobulinemia[J]. Leuk Lymphoma,
[10] WANG Y,ZHOU Y J,ZHOU K,et al. Prognostic value of
2020,61(5):1140-1146
pre ⁃ treatment red blood cell distribution width in lung
[23] CICCARELLI B T,PATTERSON C J,HUNTER Z R,et
cancer:a meta⁃analysis[J]. Biomarkers,2020,25(3):
al. Hepcidin is produced by lymphoplasmacytic cells and
241-247
is associated with anemia in Waldenström's macroglobu⁃
[11] YANG D,QUAN W,WU J,et al. The value of red blood
linemia[J]. Clin Lymphoma Myeloma Leuk,2011,11
cell distribution width in diagnosis of patients with
(1):160-163
colorectal cancer[J]. Clin Chim Acta,2018,479:98-102
[24] TREON S P,TRIPSAS C K,CICCARELLI B T,et al. Pa⁃
[12] ALBAYRAK S,ZENGIN K,TANIK S,et al. Red cell dis⁃
tients with Waldenström macroglobulinemia commonly
tribution width as a predictor of prostate cancer progres⁃
present with Iron deficiency and those with severely de⁃
sion[J]. Asian Pacific Journal of Cancer Prevention,
pressed transferrin saturation levels show response to par⁃
2014,15(18):7781-7784
enteral Iron administration[J]. Clin Lymphoma Myeloma
[13] YAO D S,WANG Z W,CAI H F,et al. Relationship be⁃
Leuk,2013,13(2):241-243
tween red cell distribution width and prognosis in patients
[25] LIPPI G,TARGHER G,MONTAGNANA M,et al. Rela⁃
with breast cancer after operation:a retrospective cohort
tion between red blood cell distribution width and inflam⁃
study[J]. Biosci Rep,2019,39(7):BSR20190740
matory biomarkers in a large cohort of unselected outpa⁃
[14] IRIYAMA N,HATTA Y,KOBAYASHI S,et al. Higher
tients[J]. Arch Pathol Lab Med,2009,133(4):628-632
red blood cell distribution width is an adverse prognostic
[26] ZHAO T,CUI L,LI A. The significance of RDW in pa⁃
factor in chronic ⁃ phase chronic myeloid leukemia pa⁃
tients with hepatocellular carcinoma after radical resection
tients treated with tyrosine kinase inhibitors[J]. Antican⁃
[J]. Cancer Biomark,2016,16(4):507-512
cer Res,2015,35(10):5473-5478
[收稿日期] 2020-11-16
[15] PODHORECKA M,HALICKA D,SZYMCZYK A,et al.